Dipen M Maru

Dipen M Maru

UNVERIFIED PROFILE

Are you Dipen M Maru?   Register this Author

Register author
Dipen M Maru

Dipen M Maru

Publications by authors named "Dipen M Maru"

Are you Dipen M Maru?   Register this Author

93Publications

3255Reads

16Profile Views

HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.

Ann Thorac Surg 2018 Feb 7;105(2):363-370. Epub 2017 Dec 7.

Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2017.09.003DOI Listing
February 2018

Arginine methylation of EGFR: a new biomarker for predicting resistance to anti-EGFR treatment.

Am J Cancer Res 2017 1;7(12):2587-2599. Epub 2017 Dec 1.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterTX 77030, Houston, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752698PMC
December 2017

The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy.

Radiother Oncol 2017 08 4;124(2):318-324. Epub 2017 Jul 4.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2017.06.019DOI Listing
August 2017

Early clinical esophageal adenocarcinoma (cT1): Utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved?

Eur J Radiol 2017 Mar 3;88:56-60. Epub 2017 Jan 3.

The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2017.01.001DOI Listing
March 2017

Metastasis regulation by PPARD expression in cancer cells.

JCI Insight 2017 01 12;2(1):e91419. Epub 2017 Jan 12.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/jci.insight.91419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214933PMC
January 2017

Oncologic Outcomes of Extended Robotic Resection for Rectal Cancer.

Ann Surg Oncol 2016 07 8;23(7):2249-57. Epub 2016 Feb 8.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5117-3DOI Listing
July 2016

Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer.

Br J Cancer 2016 06 7;114(12):1352-61. Epub 2016 Jun 7.

Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.87DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984478PMC
June 2016

Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.

J Gastrointest Surg 2016 Jan 25;20(1):6-12; discussion 12. Epub 2015 Sep 25.

Department of Surgery, Keck School of Medicine, University of Southern California, 1510 San Pablo St, Suite 514, Los Angeles, CA, 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11605-015-2950-9DOI Listing
January 2016

Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection.

Ann Thorac Surg 2015 Nov 30;100(5):1812-6. Epub 2015 Jul 30.

Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2015.05.038DOI Listing
November 2015

Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.

Ann Surg 2015 Apr;261(4):733-9

*Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX †Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan ‡Department of Surgery, Clinica Alemana Santiago, Vitacura, Santiago, Chile §Department of Pathology, Pontificia Universidad Católica, Santiago, Chile ‖Creative Bioscience, Santiago, Chile ¶Department of HPB and Digestive Surgery, Ospedale Mauriziano Umberto I, Turin, Italy **Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX ††Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000000728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800978PMC
April 2015

TP53 loss creates therapeutic vulnerability in colorectal cancer.

Nature 2015 Apr 22;520(7549):697-701. Epub 2015 Apr 22.

1] Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417759PMC
April 2015

A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer.

J Gastrointest Oncol 2015 Feb;6(1):45-52

1 Department of Radiation Oncology, 2 Department of Thoracic and Cardiovascular Surgery, 3 Department of Pathology, 4 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2078-6891.2014.054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294819PMC
February 2015

Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation.

Ann Thorac Surg 2014 Sep 16;98(3):1064-71. Epub 2014 Jul 16.

Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2014.04.099DOI Listing
September 2014

Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma.

J Natl Compr Canc Netw 2014 Aug;12(8):1139-44

From the Departments of Gastrointestinal Medical Oncology; Thoracic and Cardiovascular Surgery; Internal Medicine; Radiation Oncology; Gastroenterology, Hepatology, and Nutrition; and Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/8/1139.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0111DOI Listing
August 2014

Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?

Cancer 2014 Apr 28;120(8):1282. Epub 2014 Jan 28.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28559DOI Listing
April 2014

RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.

Ann Surg 2013 Oct;258(4):619-26; discussion 626-7

Departments of *Surgical Oncology †Gastrointestinal Medical Oncology ‡Hematopathology §Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/SLA.0b013e3182a5025aDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856211PMC
October 2013

The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma.

Ann Surg 2013 Sep;258(3):500-7

Departments of *Thoracic and Cardiovascular Surgery, †GI Medical Oncology, ‡Diagnostic Radiology, §GI Medicine & Nutrition, ¶Pathology, ‖Radiation Therapy, and **Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0b013e3182a196f4DOI Listing
September 2013

Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.

Cancer Res 2013 Apr 27;73(7):2159-69. Epub 2013 Mar 27.

Department of Gastroenterology, Hepatology & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-1962DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745222PMC
April 2013

Does the timing of esophagectomy after chemoradiation affect outcome?

Ann Thorac Surg 2012 Jan 1;93(1):207-12; discussion 212-3. Epub 2011 Oct 1.

Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2011.05.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041623PMC
January 2012

CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab.

AJR Am J Roentgenol 2011 Dec;197(6):W1060-6

Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.11.6459DOI Listing
December 2011

Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status.

Ann Thorac Surg 2010 Sep;90(3):884-90; discussion 890-1

Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2010.03.116DOI Listing
September 2010

Gadolinium chloride augments tumor-specific imaging of targeted quantum dots in vivo.

ACS Nano 2010 Jul;4(7):4131-41

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/nn901919wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090730PMC
July 2010

Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.

J Clin Oncol 2010 May 20;28(15):2549-55. Epub 2010 Apr 20.

Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.5701DOI Listing
May 2010

Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction.

Cancer 2010 Apr;116(7):1656-63

Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24935DOI Listing
April 2010

Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.

Int J Radiat Oncol Biol Phys 2010 Mar 21;76(3):824-30. Epub 2009 May 21.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.02.037DOI Listing
March 2010

Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma.

Mod Pathol 2009 Dec 4;22(12):1612-21. Epub 2009 Sep 4.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2009.133DOI Listing
December 2009

Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma.

J Thorac Cardiovasc Surg 2009 Oct 9;138(4):831-6. Epub 2009 Apr 9.

Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2009.02.003DOI Listing
October 2009

Barrett's esophagus: diagnostic challenges and recent developments.

Authors:
Dipen M Maru

Ann Diagn Pathol 2009 Jun 1;13(3):212-21. Epub 2009 Apr 1.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anndiagpath.2009.02.004DOI Listing
June 2009

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

J Clin Oncol 2008 Nov 20;26(33):5344-51. Epub 2008 Oct 20.

Department of Surgical Oncology, Gastrointestinal Medical Oncology, and Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.5299DOI Listing
November 2008

Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.

Am J Surg Pathol 2008 Sep;32(9):1404-11

Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31816bf41fDOI Listing
September 2008